Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer

被引:20
作者
Barranger, E
Kerrou, K
Petegnief, Y
David-Montefiore, E
Cortez, A
Daraï, E
机构
[1] Hop Tenon, Serv Gynecol Obstet, Dept Gynecol & Obstet, AP HP, F-75020 Paris, France
[2] Hop Tenon, Dept Nucl Med, AP HP, F-75020 Paris, France
[3] Hop Tenon, Dept Pathol, AP HP, F-75020 Paris, France
关键词
ovarian cancer; recurrence; FDG; positron emission tomography; computed tomography; occult metastasis; intraoperative probe; laparoscopy;
D O I
10.1016/j.ygyno.2004.09.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Positron emission tomography and computed tomography (PET/CT) have a potential role in detecting and locating recurrent ovarian cancer. Precise tumor location during surgical treatment is often difficult, owing to limited tumor size and post-surgical anatomic modifications. The surgical gamma probe, which has become increasing popular in recent years with the development of sentinel node mapping, may improve tumor detection and facilitate resection of occult metastases. Case report. We describe the first case of laparoscopic resection of occult metastasis using the combination of FDG-PET/CT image fusion with intraoperative FDG-sensitive probing in a patient with recurrent ovarian cancer. Conclusion. FDG-sensitive probe combined with preoperative PET/CT image fusion can help to detect occult metastasis and guide laparoscopic excision. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 16 条
[1]  
Adam LE, 2001, J NUCL MED, V42, P1821
[2]   Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma [J].
Barranger, E ;
Grahek, D ;
Cortez, A ;
Talbot, JN ;
Uzan, S ;
Darai, E .
CANCER, 2003, 97 (12) :3003-3009
[3]   Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT [J].
Bristow, RE ;
del Carmen, MG ;
Pannu, HK ;
Cohade, C ;
Zahurak, ML ;
Fishman, EK ;
Wahl, RL ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2003, 90 (03) :519-528
[4]  
Desai D C., 2000, Clin Positron Imaging, V3, P189, DOI 10.1016/S1095-0397(00)00052-2
[5]   Application of an [18F] fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy [J].
Essner, R ;
Hsueh, EC ;
Haigh, PI ;
Glass, EC ;
Huynh, Y ;
Daghighian, F .
JOURNAL OF SURGICAL RESEARCH, 2001, 96 (01) :120-126
[6]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[7]   Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma [J].
Kubik-Huch, RA ;
Dörffler, W ;
von Schulthess, GK ;
Marincek, B ;
Köchli, OR ;
Seifert, B ;
Haller, U ;
Steinert, HC .
EUROPEAN RADIOLOGY, 2000, 10 (05) :761-767
[8]   Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy [J].
Levenback, C ;
Coleman, RL ;
Burke, TW ;
Lin, WM ;
Erdman, W ;
Deavers, M ;
Delpassand, ES .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :688-693
[9]   Positron emission tomography/computed tomography Imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review [J].
Makhija, S ;
Howden, N ;
Edwards, R ;
Kelley, J ;
Townsend, DW ;
Meltzer, CC .
GYNECOLOGIC ONCOLOGY, 2002, 85 (01) :53-58
[10]   Clinical value of positron emission tomography with FDG for recurrent ovarian cancer [J].
Nakamoto, Y ;
Saga, T ;
Ishimori, T ;
Mamede, M ;
Togashi, K ;
Higuchi, T ;
Mandai, M ;
Fujii, S ;
Sakahara, H ;
Konishi, J .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (06) :1449-1454